Bipolar disorders (BDs) are recurrent and sometimes chronic disorders of mood that affect
around 2% of the world's population and encompass a spectrum between severe elevated …

Objectives Cognitive dysfunction affects a significant proportion of people with bipolar
disorder (BD), but the cause, trajectory and correlates of such dysfunction remains unclear …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Bipolar disorder is heterogeneous in phenomenology, illness trajectory, and response to
treatment. Despite evidence for the efficacy of multimodality interventions, the majority of …

People with bipolar disorder frequently experience persistent residual symptoms, problems
in psychosocial functioning, cognitive impairment, and poor quality of life. In the last decade …

Objectives Cognition is a new treatment target to aid functional recovery and enhance
quality of life for patients with bipolar disorder. The International Society for Bipolar …

Cognitive impairment occurs across several neuropsychiatric diseases and impede
everyday functioning and quality of life. Fully immersive Virtual Reality (VR) aid motivation …

Background Cognitive impairments are an emerging treatment target in mood disorders, but
currently there are no evidence‐based pro‐cognitive treatments indicated for patients in …

Objectives Cognitive impairment affects many patients with bipolar disorder (BD), and
treatments with replicated pro‐cognitive effects are lacking. This study aimed to assess the …

Objectives Cognitive remediation therapy (CRT) may benefit people with bipolar disorder
type I and II for whom cognitive impairment is a major contributor to disability. Extensive …